Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle

Nature Genetics

Volumn 27, Issue 2, 2001, Pages 195-200

  Musarò, Antonio ^a,b   McCullagh, Karl ^a   Paul, Angelika ^a   Houghton, Leslie ^a   Dobrowolny, Gabriella ^b   Molinaro, Mario ^b   Barton, Elisabeth R ^c   L Sweeney, H ^c   Rosenthal, Nadia ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; TRANSCRIPTION FACTOR GATA 2;

ADOLESCENT; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION REGULATION; MOUSE; MUSCLE HYPERTROPHY; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TRANSGENE;

ANIMALS; CACHEXIA; CELL AGING; DNA-BINDING PROTEINS; GATA2 TRANSCRIPTION FACTOR; HYPERTROPHY; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; NEURODEGENERATIVE DISEASES; ORGAN SIZE; PROTEIN ISOFORMS; REGENERATION; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0035136062     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/84839     Document Type: Article

References (29)

1. Contractile properties of skeletal muscles from young, adult and aged mice
2. Enhanced expression of myogenic regulatory factors in aging skeletal muscle
3. The cancer anorexia-cachexia syndrome
4. Growth hormone and the insulin-like growth factor system in myogenesis
5. Growth, differentation, and survival: Multiple physiological functions for insulin-like growth factors
6. Liver-derived IGF-1 is the principal source of IGF-1 in blood but is not required for postnatal body growth in mice
7. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts
8. Proliferation precedes differentiation in IGF-1 stimulated myogenesis
9. Growth enhancement of transgenic mice expressing human insulin-like growth factor-I
10. Myogenic vector expression of insulin-like growth factor I stimulate myocyte differentiation and myofiber hypertrophy in transgenic mice
11. Overexpression of insulin-like growth factor-I in the heart is coupled with myocyte proliferation in transgenic mice
12. Local insulin-like growth factor I expression induces physiologic, then pathologic cardiac hypertrophy in transgenic mice
13. Structure, expression and regulation of the IGF-1 gene
14. A transgene target for positional regulators marks early rostrocaudal specification of myogenic lineages
15. Maturation of the myogenic program is induced by post-mitotic expression of IGF-1
16. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1
17. 2+-dependent calcineurin signalling pathway
18. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
19. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition
20. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type
21. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo
22. Calcineurin co-regulates contractile and metabolic components of slow muscle phenotype
23. Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells
24. CaM kinase singaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo
25. Desmin-lacZ transgene expression and regeneration within skeletal muscle transplants
26. Viral mediated expression of IGF-1 blocks the aging-related loss of skeletal muscle function
27. Contribution of satellite cells to IGF-1 induced hypertrophy of skeletal muscle
28. At the cutting edge. Insulin-like growth factor I (IGF-1): A molecular basis for endocrine versus local action
29. Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation